Clinical Trial Update: Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery [Phase 2]

View source ↗

Summary

Results from a Phase 2, placebo-controlled study evaluating N1539 for postoperative pain after bunionectomy have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• N1539

Snippet

Sponsor: Baudax Bio | Conditions: Pain, Post-operative | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14